Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling-Reference-Cited by-同舟云学术

Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling

Published:2016-06-13 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Rodrigues-Diez Raquel,González-Guerrero Cristian,Ocaña-Salceda Carlos,Rodrigues-Diez Raúl R.,Egido Jesús,Ortiz Alberto,Ruiz-Ortega Marta,Ramos Adrián M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep27915.pdf

Reference54 articles.

1. Valantine, H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant. 23, S187–93 (2004).

2. Al-Massarani, G. et al. Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. Am J Transplant. 8, 2360–7 (2008).

3. Mitchell, R. N. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol. 4, 19–47 (2009).

4. Jiang, X., Sung, Y. K., Tian, W., Qian, J., Semenza, G. L. & Nicolls, M. R. Graft microvascular disease in solid organ transplantation. J Mol Med (Berl). 92, 797–810 (2014).

5. Navarro-Antolín, J. et al. Role of peroxynitrite in endothelial damage mediated by Cyclosporine A. Free Radic Biol Med. 42, 394–403 (2007).

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liraglutide and resveratrol alleviated cyclosporin A induced nephrotoxicity in rats through improving antioxidant status, apoptosis and pro-inflammatory markers;Biochemical and Biophysical Research Communications;2024-10

2. Adverse Pregnancy Outcomes in Solid Organ Transplant Recipients;JAMA Network Open;2024-08-29

3. Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk;Research and Practice in Thrombosis and Haemostasis;2024-08

4. Cardiovascular toxicities by calcineurin inhibitors: Cellular mechanisms behind clinical manifestations;Acta Physiologica;2024-07-10

5. Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathies without ADAMTS‐13 deficiency;European Journal of Haematology;2024-07-02